Northern Trust Corp Cuts Stock Position in Azenta, Inc. (NASDAQ:AZTA)

Northern Trust Corp cut its stake in Azenta, Inc. (NASDAQ:AZTA - Free Report) by 11.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 357,961 shares of the company's stock after selling 47,597 shares during the quarter. Northern Trust Corp owned about 0.78% of Azenta worth $17,898,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Picton Mahoney Asset Management lifted its position in Azenta by 305.7% in the fourth quarter. Picton Mahoney Asset Management now owns 706 shares of the company's stock worth $35,000 after buying an additional 532 shares during the last quarter. Headlands Technologies LLC bought a new stake in Azenta in the fourth quarter worth $40,000. Covestor Ltd lifted its position in Azenta by 64.2% in the fourth quarter. Covestor Ltd now owns 2,043 shares of the company's stock worth $102,000 after buying an additional 799 shares during the last quarter. KBC Group NV lifted its position in Azenta by 48.5% in the fourth quarter. KBC Group NV now owns 2,137 shares of the company's stock worth $107,000 after buying an additional 698 shares during the last quarter. Finally, Quarry LP bought a new stake in Azenta in the fourth quarter worth $110,000. 99.08% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on AZTA shares. Evercore ISI raised their price target on Azenta from $50.00 to $52.00 and gave the stock an "in-line" rating in a research report on Thursday, February 6th. Needham & Company LLC lowered their price target on Azenta from $59.00 to $40.00 and set a "buy" rating for the company in a research report on Wednesday, May 7th. Finally, TD Cowen upgraded Azenta to a "hold" rating in a research report on Thursday, February 27th.

Azenta Price Performance

Shares of NASDAQ:AZTA traded down $0.35 on Monday, hitting $27.12. 684,343 shares of the company's stock were exchanged, compared to its average volume of 678,823. Azenta, Inc. has a 12 month low of $23.91 and a 12 month high of $63.58. The stock has a market capitalization of $1.24 billion, a price-to-earnings ratio of -9.10 and a beta of 1.64. The business's 50 day simple moving average is $29.78 and its two-hundred day simple moving average is $41.44.

Azenta (NASDAQ:AZTA - Get Free Report) last released its earnings results on Wednesday, May 7th. The company reported $0.05 earnings per share for the quarter, missing the consensus estimate of $0.09 by ($0.04). Azenta had a positive return on equity of 1.25% and a negative net margin of 24.91%. Azenta's revenue for the quarter was up 5.1% on a year-over-year basis. During the same period in the prior year, the company earned $0.06 EPS. Equities analysts forecast that Azenta, Inc. will post 0.53 EPS for the current fiscal year.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.